Medical Use
Ngenla (somatrogon-ghla) is a once-weekly human growth hormone (hGH) analog used to treat pediatric patients aged three years and older who experience growth failure due to insufficient secretion of endogenous growth hormone.
Recommended Dosage: The suggested dosage for Ngenla injection is 0.66 mg per kg of actual body weight, administered once weekly via subcutaneous (SC) injection. It should be given on the same day each week, at any time of the day, in the upper arms, abdomen, buttocks, or thighs.
The dosage can be tailored to each patient’s growth response. If needed, the day of weekly administration can be adjusted, provided there is at least a 3-day gap between doses. Once a new dosing day is chosen, continue with the once-weekly schedule. When transitioning from daily growth hormone, the once-weekly dose can begin the day after the last daily injection. If more than one injection is required to deliver the full dose, each injection should be given at a different site.
If a dose is missed, administer it as soon as possible within 3 days of the missed dose. If more than 3 days have passed, skip the missed dose and administer the next dose on the regular schedule.
Warning & Precautions
Ngenla 24 mg/1.2 mL (20 mg/mL) or 60 mg/1.2 mL (50 mg/mL) injections should be administered under the supervision of a healthcare professional experienced in diagnosing and managing pediatric patients aged three years and older with growth hormone deficiency (GHD).
Before starting treatment with Ngenla, a fundoscopic examination is necessary to rule out preexisting papilledema. If papilledema is suspected, the underlying cause should be identified and treated before beginning Ngenla therapy.
Serious systemic hypersensitivity reactions, such as anaphylaxis and angioedema, can occur with somatropin. Immediate medical attention is required if allergic reactions develop. Ngenla should not be used in patients with known hypersensitivity to somatrogon or any of its excipients.
Ngenla treatment may decrease insulin sensitivity, especially at higher doses. Regular monitoring of glucose levels is recommended, particularly in patients with risk factors for diabetes mellitus, such as Turner syndrome, obesity, or a family history of diabetes. Patients with preexisting type 1 or type 2 diabetes mellitus or pre-diabetes should be closely monitored.
Documentation Availability
Documents required to import NGENLA to India?
NGENLA (somatrogon-ghla) injection can be imported by patients or treating physicians on behalf of patients. The following documentation is required to import the product:
- (i)2 ID proofs along with PAN card details along with attested scanned copies
- (ii)Valid doctor prescription scanned copy
- (iii)Doctor’s MCI number
- (iv)Doctor’s mobile number
- (v)Patients diagnostic reports
How is the order confirmed?
The order will be confirmed only after the receipt of:
- (i)The above-mentioned documents and drug availability.
- (ii)Import permit if applicable.
Sourcing & Delivery
The Rx4U team has extensive experience in sourcing NGENLA (Cancer Treatment Medicines) from around the world, ensuring global access to the best available treatments for our customers. We are dedicated to promptly dispensing any valid prescription. All prescriptions are verified and dispatched directly to the patient’s address. Our patients are our top priority, and we strive to improve their lives through our services.
FAQ
What is the generic name for the trade name drug Ngenla®?
The generic name for Ngenla® is somatrogon-ghla.
Who manufactures Ngenla®?
Ngenla® is manufactured by Pfizer Pharmaceuticals.
Is Ngenla® approved by the FDA?
Yes, Ngenla® received FDA approval on June 27, 2023.
What dosage and form is Ngenla® available in?
Ngenla® is available as injections: 24 mg/1.2 mL (20 mg/mL) and 60 mg/1.2 mL (50 mg/mL) single-patient-use prefilled pens for subcutaneous use.
What are the most common side effects of Ngenla®?
Common side effects include headache, injection site reactions, nasopharyngitis, rash, hypothyroidism, fever, cough, vomiting, anemia, abdominal pain, and oropharyngeal pain.
How much does Ngenla® cost in India?
The cost of Ngenla® in India can vary. To purchase it legally, you can contact the Rx4u team.
What are the storage conditions for Ngenla®?
Store Ngenla® refrigerated at 36-46°F (2-8°C) in its original carton to protect it from light. Do not freeze or shake it, and avoid using it if it has been frozen. Keep it away from direct sunlight.
Is it safe to buy Ngenla® online in India?
Yes, you can safely purchase Ngenla® online in India through https://rx4u.in/.
*Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and Rx4U does not lay any claim on them we only provide Information.
